Vividion Therapeutics

#Cancer research #Oncology #The Francis Crick Institute #Vividion Therapeutics

Research identifies compounds preventing cancer gene mutation

New research has identified chemical compounds that can precisely block the interaction between the major cancer-driving gene RAS and a key pathway for tumour growth.   Researchers from the Francis Crick Institute and Vividion Therapeutics identified compounds that can block the RAS gene from mutating without preventing the… Read More

#News